Supplementary Tables Indirect Treatment Comparisons of Avapritinib versus Midostaurin for Patients with Advanced Systemic Mastocytosis

Table A: Inclusion and exclusion criteria for the clinical systematic literature review Table B: Summary of inclusion/exclusion of studies for ITCs Table C: Comparison of C-findings at baseline Table D: Baseline characteristics across studies – safety population and FAS Table E: Overall survival results Table F: Overall response rate results Table G: Complete remission results Table H: Summary of overall response rates and complete remission rates by the IWG-MRT-ECNM response criteria

表A：临床系统文献综述纳入排除标准
表B：间接治疗比较（ITCs）的研究纳入/排除情况汇总
表C：基线期C-findings对比
表D：各项研究的基线特征——安全性人群与全分析集（FAS）
表E：总生存期结果
表F：总缓解率结果
表G：完全缓解结果
表H：基于IWG-MRT-ECNM疗效评价标准的总缓解率与完全缓解率汇总